phase 2a – Talk Bio

Regor’s Obesity Pill RGT-075 Shows Moderate Weight Loss in Phase 2a, Advances to Phase 2b Trial

3 months ago talkbio0Tagged GLP-1 receptor, Obesity, Oral Medication, phase 2a, Phase 2b Trial, RGT-075

RGT-075, obesity treatment, GLP-1 receptor agonist, oral medication, Phase 2a results, Phase 2b trial

Enanta Pharmaceuticals Achieves Breakthrough in RSV Treatment with EDP-323, Demonstrating Significant Reductions in Viral Load and Symptoms

7 months ago talkbio0Tagged Alleviation, antiviral treatment, EDP-323, Enanta, Human Challenge Study, phase 2a, Respiratory syncytial virus, Symptoms, Viral Load result

Enanta Pharmaceuticals, EDP-323, Respiratory Syncytial Virus (RSV), Antiviral Treatment, Phase 2a Human Challenge Study, Viral Load Reduction, Symptom Alleviation

Aligos Therapeutics’ HERALD Study Shows Promising MASH Treatment Results, Yet Fails to Impress Investors

7 months ago talkbio0Tagged ALG-055009, Aligos, Clinical Research, HERALD, investor, Liver, MASH, phase 2a

Aligos Therapeutics, HERALD study, MASH treatment, ALG-055009, liver fat reduction, Phase 2a results, investor reaction.